Therapy: Immunotherapy for T1DM--targeting innate immunity.
Therapy: Immunotherapy for T1DM--targeting innate immunity.
复制标题
治疗：T1DM 免疫疗法——针对先天免疫。
DOI：
10.1038/nrendo.2013.103
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Wen,Li
中科院分区：
文献类型：
--
作者：
Wong,FSusan;Wen,Li
Two trials have assessed the use of canakinumab and anakinra in patients with new-onset type 1 diabetes mellitus (T1DM). Although fairly safe, the drugs were not efficacious in terms of halting the decline in β-cell function. Is this the end of the line for targeting IL-1 in T1DM?
